Deepak K Gupta1, Hicham Skali2, Brian Claggett2, Rumen Kasabov2, Susan Cheng2, Amil M Shah2, Laura R Loehr3, Gerardo Heiss3, Vijay Nambi4, David Aguilar4, Lisa Miller Wruck3, Kunihiro Matsushita5, Aaron R Folsom6, Wayne D Rosamond3, Scott D Solomon2. 1. Vanderbilt Heart and Vascular Institute, Department of Medicine, Vanderbilt University Medical Center, Nashville, Tennessee. Electronic address: deepak.gupta@vanderbilt.edu. 2. Cardiovascular Division, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts. 3. Department of Epidemiology, University of North Carolina, Chapel Hill, North Carolina. 4. Division of Cardiology, Baylor College of Medicine, Houston, Texas. 5. Department of Epidemiology, Johns Hopkins University, Baltimore, Maryland. 6. Division of Epidemiology and Community Health, University of Minnesota, Minneapolis, Minnesota.
Abstract
OBJECTIVES: The aim of this study was to describe the relationship between ankle brachial index (ABI) and the risk for heart failure (HF). BACKGROUND: The ABI is a simple, noninvasive measure associated with atherosclerotic cardiovascular disease and death; however, the relationship between ABI and risk for HF is less well characterized. METHODS: Between 1987 and 1989 in the ARIC (Atherosclerosis Risk In Communities) study, an oscillometric device was used to measure blood pressure in a single upper and randomly chosen lower extremity to determine the ABI. Incident HF events were defined by the first hospitalization with an International Classification of Diseases, Ninth Revision, code of 428.x through 2008. The risk for HF was assessed across the ABI range using restricted cubic splines and Cox proportional hazards models. RESULTS: ABI was available in 13,150 participants free from prevalent HF. Over a mean 17.7 years of follow-up, 1,809 incident HF events occurred. After adjustment for traditional HF risk factors, prevalent coronary heart disease, subclinical carotid atherosclerosis, and interim myocardial infarction, compared with an ABI of 1.01 to 1.40, participants with ABIs ≤0.90 were at increased risk for HF (hazard ratio: 1.40; 95% confidence interval: 1.12 to 1.74), as were participants with ABIs of 0.91 to 1.00 (hazard ratio: 1.36; 95% confidence interval: 1.17 to 1.59). CONCLUSIONS: In a middle-age community cohort, an ABI ≤1.00 was significantly associated with an increased risk for HF, independent of traditional HF risk factors, prevalent coronary heart disease, carotid atherosclerosis, and interim myocardial infarction. Low ABI may reflect not only overt atherosclerosis but also pathologic processes in the development of HF beyond epicardial atherosclerotic disease and myocardial infarction alone. A low ABI, as a simple, noninvasive measure, may be a risk marker for HF.
OBJECTIVES: The aim of this study was to describe the relationship between ankle brachial index (ABI) and the risk for heart failure (HF). BACKGROUND: The ABI is a simple, noninvasive measure associated with atherosclerotic cardiovascular disease and death; however, the relationship between ABI and risk for HF is less well characterized. METHODS: Between 1987 and 1989 in the ARIC (Atherosclerosis Risk In Communities) study, an oscillometric device was used to measure blood pressure in a single upper and randomly chosen lower extremity to determine the ABI. Incident HF events were defined by the first hospitalization with an International Classification of Diseases, Ninth Revision, code of 428.x through 2008. The risk for HF was assessed across the ABI range using restricted cubic splines and Cox proportional hazards models. RESULTS: ABI was available in 13,150 participants free from prevalent HF. Over a mean 17.7 years of follow-up, 1,809 incident HF events occurred. After adjustment for traditional HF risk factors, prevalent coronary heart disease, subclinical carotid atherosclerosis, and interim myocardial infarction, compared with an ABI of 1.01 to 1.40, participants with ABIs ≤0.90 were at increased risk for HF (hazard ratio: 1.40; 95% confidence interval: 1.12 to 1.74), as were participants with ABIs of 0.91 to 1.00 (hazard ratio: 1.36; 95% confidence interval: 1.17 to 1.59). CONCLUSIONS: In a middle-age community cohort, an ABI ≤1.00 was significantly associated with an increased risk for HF, independent of traditional HF risk factors, prevalent coronary heart disease, carotid atherosclerosis, and interim myocardial infarction. Low ABI may reflect not only overt atherosclerosis but also pathologic processes in the development of HF beyond epicardial atherosclerotic disease and myocardial infarction alone. A low ABI, as a simple, noninvasive measure, may be a risk marker for HF.
Authors: Victor Aboyans; Michael H Criqui; Robyn L McClelland; Matthew A Allison; Mary McGrae McDermott; David C Goff; Teri A Manolio Journal: J Vasc Surg Date: 2007-02 Impact factor: 4.268
Authors: Hossein Bahrami; Richard Kronmal; David A Bluemke; Jean Olson; Steven Shea; Kiang Liu; Gregory L Burke; João A C Lima Journal: Arch Intern Med Date: 2008-10-27
Authors: Laura R Loehr; Wayne D Rosamond; Patricia P Chang; Aaron R Folsom; Lloyd E Chambless Journal: Am J Cardiol Date: 2008-02-14 Impact factor: 2.778
Authors: F G R Fowkes; G D Murray; I Butcher; C L Heald; R J Lee; L E Chambless; A R Folsom; A T Hirsch; M Dramaix; G deBacker; J-C Wautrecht; M Kornitzer; A B Newman; M Cushman; K Sutton-Tyrrell; F G R Fowkes; A J Lee; J F Price; R B d'Agostino; J M Murabito; P E Norman; K Jamrozik; J D Curb; K H Masaki; B L Rodríguez; J M Dekker; L M Bouter; R J Heine; G Nijpels; C D A Stehouwer; L Ferrucci; M M McDermott; H E Stoffers; J D Hooi; J A Knottnerus; M Ogren; B Hedblad; J C Witteman; M M B Breteler; M G M Hunink; A Hofman; M H Criqui; R D Langer; A Fronek; W R Hiatt; R Hamman; H E Resnick; J Guralnik; M M McDermott Journal: JAMA Date: 2008-07-09 Impact factor: 56.272
Authors: Ning Cheung; A Richey Sharrett; Ronald Klein; Michael H Criqui; F M Amirul Islam; Katarzyna J Macura; Mary Frances Cotch; Barbara E K Klein; Tien Y Wong Journal: Hypertension Date: 2007-08-13 Impact factor: 10.190
Authors: Anna Kottgen; Stuart D Russell; Laura R Loehr; Ciprian M Crainiceanu; Wayne D Rosamond; Patricia P Chang; Lloyd E Chambless; Josef Coresh Journal: J Am Soc Nephrol Date: 2007-03-07 Impact factor: 10.121
Authors: Beth D Weatherley; Jeanenne J Nelson; Gerardo Heiss; Lloyd E Chambless; A Richey Sharrett; F Javier Nieto; Aaron R Folsom; Wayne D Rosamond Journal: BMC Cardiovasc Disord Date: 2007-01-16 Impact factor: 2.298
Authors: Maria Teresa B Abola; Jonathan Golledge; Tetsuro Miyata; Seung-Woon Rha; Bryan P Yan; Timothy C Dy; Marie Simonette V Ganzon; Pankaj Kumar Handa; Salim Harris; Jiang Zhisheng; Ramakrishna Pinjala; Peter Ashley Robless; Hiroyoshi Yokoi; Elaine B Alajar; April Ann Bermudez-Delos Santos; Elmer Jasper B Llanes; Gay Marjorie Obrado-Nabablit; Noemi S Pestaño; Felix Eduardo Punzalan; Bernadette Tumanan-Mendoza Journal: J Atheroscler Thromb Date: 2020-07-04 Impact factor: 4.928
Authors: Kunihiro Matsushita; Shoshana H Ballew; Yingying Sang; Corey Kalbaugh; Laura R Loehr; Alan T Hirsch; Hirofumi Tanaka; Gerardo Heiss; B Gwen Windham; Elizabeth Selvin; Josef Coresh Journal: Atherosclerosis Date: 2016-11-23 Impact factor: 5.162
Authors: Razvan Anghel; Cristina Andreea Adam; Ovidiu Mitu; Dragos Traian Marius Marcu; Viviana Onofrei; Mihai Roca; Alexandru Dan Costache; Radu Stefan Miftode; Grigore Tinica; Florin Mitu Journal: Diagnostics (Basel) Date: 2022-06-20